Currently, several tumor markers, including carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are utilized for monitoring disease progression and recurrence in CRC patients [3]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.